These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25683095)

  • 1. Diagnosing phaeochromocytoma/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging.
    Amar L; Eisenhofer G
    Clin Endocrinol (Oxf); 2015 Sep; 83(3):298-302. PubMed ID: 25683095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
    Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
    Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
    Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
    Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
    Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-centre study of the diagnostic performance of plasma metanephrines with seated sampling for the diagnosis of phaeochromocytoma/paraganglioma.
    Boot C; Toole B; Johnson SJ; Ball S; Neely D
    Ann Clin Biochem; 2017 Jan; 54(1):143-148. PubMed ID: 27170024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated
    Eisenhofer G; Prejbisz A; Peitzsch M; Pamporaki C; Masjkur J; Rogowski-Lehmann N; Langton K; Tsourdi E; Pęczkowska M; Fliedner S; Deutschbein T; Megerle F; Timmers HJLM; Sinnott R; Beuschlein F; Fassnacht M; Januszewicz A; Lenders JWM
    Clin Chem; 2018 Nov; 64(11):1646-1656. PubMed ID: 30097498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
    Sbardella E; Maunsell Z; May CJH; Tadman M; James T; Jafar-Mohammadi B; Isidori AM; Grossman AB; Shine B
    Eur J Endocrinol; 2020 Aug; 183(2):129-139. PubMed ID: 32413848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory evaluation of pheochromocytoma and paraganglioma.
    Eisenhofer G; Peitzsch M
    Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
    van Berkel A; Lenders JW; Timmers HJ
    Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
    Bokuda K; Yatabe M; Seki Y; Ichihara A
    Hypertens Res; 2020 Jun; 43(6):543-549. PubMed ID: 32020083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
    Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.
    Sawka AM; Jaeschke R; Singh RJ; Young WF
    J Clin Endocrinol Metab; 2003 Feb; 88(2):553-8. PubMed ID: 12574179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of plasma fractionated free metanephrines by enzyme immunoassay in the diagnosis of pheochromocytoma and paraganglioma.
    Sarathi V; Pandit R; Jagtap V; Lila AR; Bandgar TR; Menon PS; Varthakavi P; Raghavan VP; Shah NS
    Endocr Pract; 2011; 17(5):759-65. PubMed ID: 21742610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inpatient Measurements of Urine Metanephrines are Indistinguishable from Pheochromocytoma: Retrospective Cohort Study.
    Kline GA; Boyd J; Sadrzadeh HSM; Leung AA
    Am J Med; 2021 Aug; 134(8):1039-1046.e3. PubMed ID: 33864763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
    Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.